Biontech investor calendar
WebMar 13, 2024 · 02.28.2024. Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older … WebFinancial Calendar BioNTech - investors.biontech.de
Biontech investor calendar
Did you know?
WebApr 7, 2024 · Economic Calendar; Earnings; IPO Calendar; Dividend Calendar; ... The projected annual revenue for BioNTech SE is $9,869MM, a decrease of 42.99%. ... data-driven investors. With coverage of over ... WebNov 7, 2024 · BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on November 7, 2024 at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the third quarter of 2024. To access the live conference call via telephone, please register via this link.
WebApr 10, 2024 · In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 … WebBioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. ... 422 Number of Organizations • $74.6B Total Funding Amount • 501 Number of Investors. Track . Europe Public Companies . 6,401 Number of Organizations • $342.3B Total Funding Amount • 3,941 Number of Investors.
WebNov 13, 2024 · All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law. CONTACTS. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 [email protected]. Investor Relations Sylke Maas, PhD. +49 (0)6131 9084 1074 … WebAug 9, 2024 · BioNTech stock analysts called for the company to earn $33.12 a share on $14.68 billion in sales for the year. BioNTech stock has a perfect Relative Strength Rating of 99, according to IBD Digital ...
Web1 day ago · BIONTECH SE company earnings calendar and analyst expectations - Upcoming and past events Bolsa de Valores de Sao Paulo: B1NT34 Bolsa de Valores …
WebOct 9, 2024 · Funding. BioNTech has raised a total of $1.7B in funding over 9 rounds. Their latest funding was raised on Apr 14, 2024 from a Post-IPO Equity round. BioNTech is … supreme snow removalWeb2 days ago · BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific … barber marineWebApr 7, 2024 · Economic Calendar; Earnings; IPO Calendar; Dividend Calendar; ... The projected annual revenue for BioNTech SE is $9,869MM, a decrease of 42.99%. ... data … supreme soslu piliçWebApr 29, 2024 · BioNTech Media Relations Jasmina Alatovic Senior Manager Global External Communications Tel: +49 (0)6131 9084 7640 or +49 (0)151 1978 1385 E-mail: [email protected] BioNTech Investor Relations supreme snusWebMar 23, 2024 · Every investor in BioNTech SE (NASDAQ:BNTX) should be aware of the most powerful shareholder groups. We can see that private equity firms own the lion's share in the company with 43% ownership. supreme snowboard pcWebMar 18, 2024 · For their portion of the partnership, Fosun paid $50 million to purchase 1.58 million BioNTech shares, and will provide $85 million for development and commercialization fees. supreme snow gogglesWebJun 5, 2024 · Calendars. Trending Tickers. Stocks: Most Actives. Stocks: Gainers. Stocks: Losers. Top ETFs. ... E-mail: [email protected]. Media Relations Jasmina Alatovic VP Corporate Communications Tel ... supreme souvlaki